Olympus Corporation (TYO:7733)

Market Cap	1.63T -39.0%
Revenue (ttm)	987.51B +0.2%
Net Income	84.83B +1.3%
EPS	75.69 +4.6%
Shares Out	1.10B
PE Ratio	19.56
Forward PE	16.46
Dividend	30.00 (2.03%)
Ex-Dividend Date	Mar 30, 2026

Volume	8,475,700
Average Volume	4,847,745
Open	1,535.00
Previous Close	1,548.00
Day's Range	1,480.00 - 1,539.50
52-Week Range	1,443.00 - 2,168.00
Beta	0.24
RSI	22.40
Earnings Date	Feb 13, 2026

About Olympus

Olympus Corporation, together with its subsidiaries, manufactures and sells medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through Endoscopic Solutions Business, Therapeutic Solutions Business, and Other segments. The company offers gastrointestinal endoscopy system products comprising video endoscopy and ultrasound systems; GI endotherapy products consisting of CRC devices and HPB devices/hemostasis products; endoscopic solutions ecosystem products, including intelligent ecosystem operating software platfo...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1919
• Employees: 29,297
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7733

Financial Performance

In fiscal year 2025, Olympus's revenue was 997.33 billion, an increase of 6.53% compared to the previous year's 936.21 billion. Earnings were 117.86 billion, a decrease of -51.41%.